Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VIVUS Inc (NASDAQ:VVUS)

1.01
Delayed Data
As of 3:59pm ET
 -0.02 / -1.94%
Today’s Change
0.93
Today|||52-Week Range
1.75
-12.17%
Year-to-Date

Today’s Trading

Previous close1.03
Today’s open1.02
Day’s range1.01 - 1.05
Volume389,964
Average volume (3 months)557,848
Market cap$108.8M
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-327.27%
Earnings growth (next 5 years)+0.84%
Revenue growth (last year)+30.21%
P/E ratio4.6
Price/Sales0.97
Price/Book5.94

Competitors

 Today’s
change
Today’s
% change
GLYCGlycoMimetics Inc-0.21-4.66%
ARLZAralez Pharmaceutica...-0.02-1.23%
SRNESorrento Therapeutic...-0.15-7.14%
CRMECardiome Pharma Corp+0.02+0.60%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$124.3M
Annual profit (last year)$23.3M
Net profit margin18.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Seth H. Z. Fischer
Chief Financial &
Accounting Officer
Mark K. Oki
Corporate headquarters
Campbell, California

Forecasts